| Literature DB >> 23908464 |
Arianne Perez-Garcia1, Alberto Ambesi-Impiombato, Michael Hadler, Isaura Rigo, Charles A LeDuc, Kara Kelly, Chaim Jalas, Elisabeth Paietta, Janis Racevskis, Jacob M Rowe, Martin S Tallman, Maddalena Paganin, Giuseppe Basso, Wei Tong, Wendy K Chung, Adolfo A Ferrando.
Abstract
The SH2B adaptor protein 3 (SH2B3) gene encodes a negative regulator of cytokine signaling with a critical role in the homeostasis of hematopoietic stem cells and lymphoid progenitors. Here, we report the identification of germline homozygous SH2B3 mutations in 2 siblings affected with developmental delay and autoimmunity, one in whom B-precursor acute lymphoblastic leukemia (ALL) developed. Mechanistically, loss of SH2B3 increases Janus kinase-signal transducer and activator of transcription signaling, promotes lymphoid cell proliferation, and accelerates leukemia development in a mouse model of NOTCH1-induced ALL. Moreover, extended mutation analysis showed homozygous somatic mutations in SH2B3 in 2 of 167 ALLs analyzed. Overall, these results demonstrate a Knudson tumor suppressor role for SH2B3 in the pathogenesis of ALL and highlight a possible link between genetic predisposition factors in the pathogenesis of autoimmunity and leukemogenesis.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23908464 PMCID: PMC3790510 DOI: 10.1182/blood-2013-05-500850
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113